XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Fair value of the acquisition (Details) - USD ($)
shares in Thousands
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2024
Restructuring Cost and Reserve [Line Items]      
Inventory $ 2,019,000 $ 2,191,000 $ 2,588,000
Right-of-use assets 161,000 $ 116,000  
Goodwill (unallocated intangible value) $ 33,909,000    
ENvue Medical Holdings Corp [Member]      
Restructuring Cost and Reserve [Line Items]      
Common Stock consideration 4,400,000    
Series X Preferred Stock consideration 35,000,000    
Total purchase price 39,400,000    
Net working capital $ (940,000,000)    
Inventory 395,000,000    
Fixed assets, net 112,000,000    
Right-of-use assets 58,000,000    
Lease liability LT (14,000,000)    
Total allocated tangible assets (389,000,000)    
Tradename and trademarks 560,000,000    
Proprietary technology 3,500,000,000    
Customer relationships 1,820,000,000    
Goodwill (unallocated intangible value) $ 33,909,000,000